Data Sheet - Medsafe
largactil-ccdsv1-dsv8-05aug16 1 Data Sheet Largactil NAME OF THE MEDICINE Tablets, Injection - chlorpromazine hydrochloride DESCRIPTION Chemical structure of chlorpromazine hydrochloride:
Download Data Sheet - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION …
pp.jazzpharma.com4 Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an
HALDOL Injection - Janssen
www.janssen.comCCDS 170522 3 HALDOL(170907)API The mechanism for this increased risk is not known. An increased risk cannot be excluded for other patient
DATASHEET - Medsafe
www.medsafe.govt.nznozinan-ccsiv1-dsv11-18jan17 3 death) or infectious (e.g. pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase
MHRA PUBLIC ASSESSMENT REPORT - GOV.UK
www.mhra.gov.ukinformation that could definitely establish a link, there is a possibility that antipsychotic treatment may have led to a VTE in a number of cases.
Cannabidiol, a Cannabis sativa constituent, as an ...
www.scielo.br423 Braz J Med Biol Res 39(4) 2006 Cannabidiol as an antipsychotic drug single-photon emission computed tomogra-phy. Because the procedure, by itself, can be
Aripiprazole Oral Once-Weekly - Drug Reformulation
www.zysis.comBackground Aripiprazole (brand name Abilify®) is an excellent atypical antipsychotic with a unique partial agonist mode of action. It …
PATIENT COUNSELING INFORMATION - aristada.com
www.aristada.com• Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. (5.1) • ARISTADA INITIO is not approved for the treatment of …